510(k) Report

510(k) · Cleared

Cleared

Pascal Laser Indirect Ophthalmoscope

K123056510(k) SpecialCleared Nov 13, 201243-day reviewClass II21 CFR 886.4390

Data to Oct 25, 2026 (FDA decisions) Oct 12, 2026 (recalls) Sep 30, 2026 (MAUDE) refreshed weekly, last Nov 3, 2026

Topcon Medical Laser Systems, Inc. (Tmls) · HQF Laser, Ophthalmic

Cleared on Nov 13, 2012 as substantially equivalent to K062336 (Optimedica Corporation, 2006) and 1 other predicate after a 43-day review. Its family tree reaches back 8 generations to 1989.

Decided
Nov 13, 2012
Review
43 days
Class
Class II
Product code
HQF
Recalls
None
Predicates
2

Its longest line of descent runs back 8 generations to K894841 (1989). 50 ancestors in all, the oldest K812219 (1981). No later device cites it as a predicate yet.

Other ancestors, by year cleared 2006: 1 other ancestor2009: 1 other ancestor2008: 1 other ancestor2005: 2 other ancestors2002: 3 other ancestors1999: 2 other ancestors1993: 3 other ancestors2003: 1 other ancestor2000: 1 other ancestor1996: 1 other ancestor1994: 3 other ancestors1991: 4 other ancestors1989: 5 other ancestors1983: 2 other ancestors1981: 1 other ancestor1998: 1 other ancestor1997: 3 other ancestors1986: 2 other ancestors1984: 2 other ancestors1990: 2 other ancestors1985: 1 other ancestorK894841 · Iris Oculight (TM) SL · Iriderm Div. · 1989K960971 · Oculight GL · Iriderm Div. · 1996K020374 · Oculight SL/SLX · Iridex Corp · 2002K043486 · Pascal Photocoagulator, Product-Pascal-01 · Topcon Medical Laser Systems, Inc. · 2005×2: 2 generations cleared close together, K091666 (2009), K092621 (2009) K100019 · Pascal Streamline Photocoagulator · Optimedica Corporation · 2010 · recalledK111108 · Pascal Streamline 577 (with Accessories) · Topcon Medical Laser Systems, Inc. · 20111980198519901995200020052010
  1. Root · 8 generations backK894841 Iris Oculight (TM) SLIriderm Div. · 1989
  2. 7 generations backK960971 Oculight GLIriderm Div. · 1996
  3. 6 generations backK020374 Oculight SL/SLXIridex Corp · 2002
  4. 5 generations backK043486 Pascal Photocoagulator, Product-Pascal-01Topcon Medical Laser Systems, Inc. · 2005
  5. 4 generations backK091666 Pascal Photocoagulator, Pascal-USOptimedica Corporation · 2009
  6. 3 generations backK092621 Pascal Streamline PhotocoagulatorTopcon Medical Laser Systems, Inc. · 2009
  7. 2 generations backK100019 Pascal Streamline PhotocoagulatorOptimedica Corporation · 2010 · Recalled
  8. 1 generation backK111108 Pascal Streamline 577 (with Accessories)Topcon Medical Laser Systems, Inc. · 2011
  9. This deviceK123056 Pascal Laser Indirect OphthalmoscopeTopcon Medical Laser Systems, Inc. (Tmls) · 2012
View FIG. 1 as a table

Line of descent and top descendants

GenerationNumberDeviceApplicantDecidedRecalls
−8K894841Iris Oculight (TM) SLIriderm Div.1989—
−7K960971Oculight GLIriderm Div.1996—
−6K020374Oculight SL/SLXIridex Corp2002—
−5K043486Pascal Photocoagulator, Product-Pascal-01Topcon Medical Laser Systems, Inc.2005—
−4K091666Pascal Photocoagulator, Pascal-USOptimedica Corporation2009—
−3K092621Pascal Streamline PhotocoagulatorTopcon Medical Laser Systems, Inc.2009—
−2K100019Pascal Streamline PhotocoagulatorOptimedica Corporation20101
−1K111108Pascal Streamline 577 (with Accessories)Topcon Medical Laser Systems, Inc.2011—
0 (this device)K123056Pascal Laser Indirect OphthalmoscopeTopcon Medical Laser Systems, Inc. (Tmls)2012—

Other ancestors by year cleared

Year clearedDevicesWith a Class I recall
198110
198320
198420
198510
198620
198950
199020
199140
199330
199430
199610
199730
199810
199920
200010
200230
200310
200520
200610
200810
200910
FIG. 1 — Lineage of K123056, 1989–2012Source: FDA 510(k) summaries, read by 510(k) Report · How lineage is built

Get the monthly Device Review Tracker

Notable FDA decisions, review times and new Class I recalls. See an issue.

Sources: FDA 510(k) database (decision fields), the FDA summary (predicates and indications), FDA recall and enforcement reports, and MAUDE; processed by 510(k) Report. Verify on FDA.gov · Methodology and accuracy.

Planning a device in HQF? A 510(k) Report weighs predicate choices, recall history and review times for a new device like this one.

Top candidate predicates for a new HQF device

  1. #1 K251772 Navilas Laser System 577sl (156691)score 13.6 · 12 generations · no Class I recall
  2. #2 Held for the reportin the report
  3. #3 Held for the reportin the report
Get a 510(k) Report

What was it cleared against? (2)

Devices the submitter claimed this one is substantially equivalent to (*), and reference devices cited for a specific test or feature (†), as written in the FDA summary.

TypeNumberDeviceApplicantDecidedRecalls
*K062336Optimedica Laser Indirect Ophthalmoscope
Summary page 1
…in General and Plastic Surgery and Dermatology 111. Predicate Devices " Optimedica Laser Indirect Ophthalmoscope (K062336) " Topcon Laser Indirect Ophthalmoscope (K1111O8) IV. Product Description The PASCAL Laser Indirect Oph…
Optimedica Corporation2006—
*K111108Pascal Streamline 577 (with Accessories)
Summary page 2
…Ophthalmoscope are substantially equivalent to those of the predicate devices. K062336 K111108 The PASCAL® Laser Indirect Topcon LIO LIO Ophthalmoscope Topcon (form…
Topcon Medical Laser Systems, Inc.2011—

What descends from it?

No later submission names this one as a predicate yet.

Has anything in its family been recalled? (0 Class I)

No FDA recall names this device.

No ancestor or descendant has a Class I recall.

What does this lineage say?

  • The line of descent spans 23 years and passes through 5 companies; a new generation was cleared every 2.8 years on median.
  • 2 of the 50 ancestors have a recall of any class.

How does its category compare?

All HQF devices

HQF Laser, Ophthalmic: FDA decisions, review times, recalls and adverse event reports over 20 years. 2012, this device’s year, is highlighted.

FDA decisions per year · HQF

3in 2025

2007: 42008: 32009: 72010: 22011: 42012: 52013: 62014: 32015: 42016: 32017: 32018: 12019: 42020: 42021: 12022: 72023: 52024: 32025: 32026 (partial year): 2
2007high 7 (2009) · low 1 (2018)2026

2026 to Oct 25, outlined.

Median 510(k) review, days · HQF

264in 2025

2007: 198 days median2008: 28 days median2009: 115 days median2011: 128 days median2012: 179 days median2013: 225 days median2014: 215 days median2015: 295 days median2016: 271 days median2017: 189 days median2019: 107 days median2020: 53 days median2022: 86 days median2023: 155 days median2024: 167 days median2025: 264 days median
2007high 295 (2015) · low 28 (2008)2026

Receipt to decision; years with fewer than 3 clearances left blank.

Recalls per year · HQF

1in 2025

2007: 22008: 12009: 22010: 32011: 52012: 12013: 22014: 42025: 1
2007high 5 (2011) · low 0 (2015)2026

Class I (0 since 2007) Class II/III not classified

Adverse event reports per year · HQF

106in 2025

2007: 602008: 342009: 332010: 432011: 262012: 412013: 392014: 582015: 802016: 1082017: 772018: 822019: 662020: 722021: 1002022: 1112023: 922024: 752025: 106
2007high 111 (2022) · low 26 (2011)2025

MAUDE reports naming product code HQF, not matched to any one device; reports are not rates.

View these four charts as a table
YearDecisionsMedian 510(k) review, daysRecalls (Class I)MAUDE reports
20074198260
2008328134
20097115233
20102—343
20114128526
20125179141
20136225239
20143215458
20154295080
201632710108
20173189077
20181—082
20194107066
2020453072
20211—0100
20227860111
20235155092
20243167075
202532641106
20262—0—

What is it indicated for?

The PASCAL® Laser Indirect Ophthalmoscope is intended for use with the PASCAL Streamline 577 laser or the PASCAL Streamline 532 laser when either of those lasers is used in the treatment of ocular pathology in the posterior segment; retinal photocoagulation, panretinal photocoagulation, focal photocoagulation and grid photocoagulation for vascular and structural abnormalities of the retina and choroid including: 532nm macular edema age-related macular…

Read the full statement (115 words)

The PASCAL® Laser Indirect Ophthalmoscope is intended for use with the PASCAL Streamline 577 laser or the PASCAL Streamline 532 laser when either of those lasers is used in the treatment of ocular pathology in the posterior segment; retinal photocoagulation, panretinal photocoagulation, focal photocoagulation and grid photocoagulation for vascular and structural abnormalities of the retina and choroid including:

532nm

macular edema

age-related macular degeneration

lattice degeneration

retinal tears and detachments

577nm

proliferative and nonproliferative diabetic retinopathy

macular edema

choroidal neovascularization

branch and central retinal vein occlusion

age-related macular degeneration

lattice degeneration

retinal tears and detachments

retinopathy of prematurity

Intended for use in the treatment of ocular pathology in the anterior segment including:

577nm

iridotomy

trabeculoplasty

Indications for use as stated in the FDA summary.

Cite this page

510(k) Report. “K123056: Pascal Laser Indirect Ophthalmoscope.” Lineage record from FDA 510(k) data and the FDA summary. Updated Nov 3, 2026. Accessed Nov 6, 2026. https://510kreport.com/device/K123056

Report an extraction error

Tell us what is wrong; we check it against the FDA summary.

Are you the manufacturer?

Send a correction or an update to this page, for example a newer model or a public statement about a recall.

Record history
  • FDA decision record loaded May 2, 2026
  • Summary read Oct 13, 2026 (extraction version 9eaa42aa01ed)
  • Lineage and recalls computed Nov 3, 2026
  • Page last updated Nov 3, 2026